Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Aug 2026, 00:02
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
**Standard Shift Narrative for SUNPHARMA (SUNPHARMA) on August 22, 2026** SUNPHARMA's 78.92% has accelerated from 23.25% in its previous quarter.
The company's .25% has also shown an accelerating trend from 20.19%. On the other hand, SUNPHARMA's .5% has been decelerating from 27.4% in its previous quarter. Additionally, the . The company's 1,491,879 shares has shown a decelerating trend from 2,359,670 shares in the previous day.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 78.92 % | 23.25 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 23.25 % | 20.19 | ▲ |
| REVENUE_GROWTH_YOY | 10.5 % | 27.4 | ▼ |
| EPS_ACTUAL | 13 INR | 15.482 | ▼ |
| EPS_SURPRISE_PERCENT | 0.086 % | 0.216 | ▼ |
| PRICE_CHANGE_PERCENT | -0.084 % | — | - |
| DAILY_VOLUME | 14,91,879 shares | 23,59,670 | ▼ |
| CLOSE_PRICE | 1,902.4 INR | 1,904 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.74 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 10 count | 19 | ▼ |
| TARGET_PRICE_PREMIUM | 13.92 % | — | - |